首页> 外文期刊>Journal of clinical sleep medicine: JCSM : official publication of the American Academy of Sleep Medicine >Patient-Reported Outcomes in Older Adults With Obstructive Sleep Apnea Treated With Continuous Positive Airway Pressure Therapy
【24h】

Patient-Reported Outcomes in Older Adults With Obstructive Sleep Apnea Treated With Continuous Positive Airway Pressure Therapy

机译:持续气道正压通气治疗老年阻塞性睡眠呼吸暂停的患者的结果

获取原文
       

摘要

Study Objectives:Although continuous positive airway pressure (CPAP) therapy is regarded as the gold standard treatment for obstructive sleep apnea (OSA) in adults, outcomes in older patients are limited. This study examines the effect of CPAP therapy in older adults with OSA (older than 60 years) compared to younger adults (age 18 to 60 years) to inform the current standard of practice.Methods:We performed a retrospective study with a convenience sample to compare responses to CPAP treatment in older versus younger adults with OSA using validated, patient-reported outcomes (PROs). A total of 532 patients were analyzed at baseline and at 3, 6, and 12 months after CPAP initiation. The effects of CPAP adherence and OSA severity on PRO scores were measured in each age group.Results:Patients older than 60 years had higher apnea-hypopnea indices but lower Epworth Sleepiness Scale (ESS), Fatigue Severity Scale (FSS), and Patient Health Questionnaire-9 (PHQ-9) scores and higher Functional Outcomes of Sleep Questionnaire (FOSQ) scores at baseline compared to patients age 18 to 60 years. At 1 year after CPAP initiation, significant and comparable improvements in ESS, FSS, PHQ-9, and FOSQ scores were observed in patients older than 60 years relative to younger patients. When stratifying by OSA severity, change between age groups was significantly different only for PHQ-9 in patients with mild OSA, with greater improvements observed in younger patients.Conclusions:This study adds to the limited data on treatment outcomes with CPAP therapy in older adults with OSA. Patients older than 60 years achieve improvement in sleepiness, fatigue, depressive symptoms, and quality of life analogous to that of younger adults.
机译:研究目标:尽管持续气道正压通气(CPAP)治疗被视为成人阻塞性睡眠呼吸暂停(OSA)的金标准治疗,但老年患者的预后有限。这项研究调查了CPAP治疗对OSA年龄较大的成年人(60岁以上)与年轻成年人(18至60岁)相比的疗效,从而为当前的实践标准提供了方法。使用经过验证的,患者报告的结局(PRO),比较OSA的老年人与年轻人对CPAP治疗的反应。在CPAP启动后以及基线,3、6和12个月时对总共532名患者进行了分析。结果:60岁以上的患者呼吸暂停低通气指数较高,但Epworth嗜睡量表(ESS),疲劳严重程度量表(FSS)和患者健康水平较低。与18至60岁的患者相比,基线时问卷9(PHQ-9)得分更高,睡眠功能问卷结果(FOSQ)更高。在开始CPAP的1年后,相对于年轻患者,年龄在60岁以上的患者在ESS,FSS,PHQ-9和FOSQ评分方面有显着且可比的改善。当按OSA严重程度分层时,仅轻度OSA患者的年龄组之间的变化仅对PHQ-9有显着差异,而在年轻患者中观察到的改善更大。结论:本研究增加了老年人CPAP治疗的治疗结果的有限数据与OSA。年龄超过60岁的患者在睡眠,疲劳,抑郁症状和生活质量方面的改善均类似于年轻人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号